Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation StudyNovelty and Significance

Title
Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation StudyNovelty and Significance
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 118, Issue 1, Pages 73-82
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2015-12-02
DOI
10.1161/circresaha.115.306223

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started